# Comparing Cefepime Versus Cefazolin Plus Ceftazidime for CAPD-associated Peritonitis

> **NCT02872038** · PHASE4 · COMPLETED · sponsor: **Chulalongkorn University** · enrollment: 154 (actual)

## Conditions studied

- Peritoneal Dialysis Associated Peritonitis

## Interventions

- **DRUG:** Cefepime
- **DRUG:** Cefazolin plus Ceftazidime

## Key facts

- **NCT ID:** NCT02872038
- **Lead sponsor:** Chulalongkorn University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08
- **Primary completion:** 2016-11-30
- **Final completion:** 2016-11-30
- **Target enrollment:** 154 (ACTUAL)
- **Last updated:** 2017-10-31

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02872038

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02872038, "Comparing Cefepime Versus Cefazolin Plus Ceftazidime for CAPD-associated Peritonitis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02872038. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*